Display options
Cite
Targum SD, Murphy C, Khan J, et al. Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innov Clin Neurosci. 2018;15(3):37-42
Targum, S. D., Murphy, C., Khan, J., Zumpano, L., Whitlock, M., Simen, A. A., & Binneman, B. (2018). Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innovations in clinical neuroscience, 15(3), 37-42.
Targum, Steven D, et al. "Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder." Innovations in clinical neuroscience vol. 15,3 (2018): 37-42.
Targum SD, Murphy C, Khan J, Zumpano L, Whitlock M, Simen AA, Binneman B. Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder. Innov Clin Neurosci. 2018 Apr 01;15(3):37-42. PMID: 29721364; PMCID: PMC5919431.
Copy Download .nbib Format: NLM
Share it on

Innov Clin Neurosci. 2018 Apr 01;15(3):37-42.

Audio Recording for Independent Confirmation of Clinical Assessments in Generalized Anxiety Disorder.

Innovations in clinical neuroscience

Steven D Targum, Christopher Murphy, Jibran Khan, Laura Zumpano, Mark Whitlock, Arthur A Simen, Brendon Binneman

Affiliations

  1. Drs. Targum and Murphy are with Bracket Global LLC in Boston, Massachusetts.
  2. Dr. Khan was with Bracket Global LLC in Boston, Massachusetts, at the time of this study.
  3. Ms. Zumpano is with Pfizer Inc. in New York, United States.
  4. Dr. Whitlock is with Pfizer Inc. in Cambridge, United Kingdom.
  5. Dr. Simen was with Pfizer Inc. at the time of the study but is now with Takeda Pharmaceuticals in Cambridge, Massachusetts.
  6. Dr. Binneman was with Pfizer Inc. in Cambridge, Massachusetts, at the time of this study (†deceased).

PMID: 29721364 PMCID: PMC5919431

[No abstract available.]

Keywords: Generalized anxiety disorder (GAD); anxiolytic medications; anxious symptoms; audio-digital recording; dual review; second opinions

Conflict of interest statement

FUNDING:Pfizer sponsored this study. Support for this study came from the sponsor Pfizer (Cambridge, Massachusetts) to conduct quality assurance in a clinical trial with additional support for the dat

References

  1. Arch Gen Psychiatry. 2010 Jan;67(1):47-57 - PubMed
  2. Depress Anxiety. 2010 Feb;27(2):134-47 - PubMed
  3. J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 - PubMed
  4. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 - PubMed
  5. Br J Med Psychol. 1959;32(1):50-5 - PubMed
  6. Am Fam Physician. 2009 May 1;79(9):785-91 - PubMed
  7. J Nerv Ment Dis. 1969 Jan;148(1):87-98 - PubMed
  8. Arch Intern Med. 2006 May 22;166(10):1092-7 - PubMed
  9. Expert Rev Neurother. 2004 Mar;4(2):285-94 - PubMed
  10. Ann Gen Psychiatry. 2013 Jan 31;12(1):2 - PubMed
  11. BMJ. 2011 Mar 11;342:d1199 - PubMed
  12. Depress Anxiety. 2002;16(4):162-71 - PubMed
  13. Dtsch Arztebl Int. 2013 Apr;110(17):300-9; quiz 310 - PubMed
  14. J Anxiety Disord. 2009 Dec;23(8):1086-90 - PubMed
  15. BMJ. 2012 Nov 27;345:e7500 - PubMed
  16. Psychol Med. 2008 Mar;38(3):365-74 - PubMed
  17. Eur Neuropsychopharmacol. 2014 Nov;24(11):1760-6 - PubMed
  18. J Clin Psychiatry. 1999 Jul;60(7):427-35 - PubMed

Publication Types